Lineage Cell Therapeutics, Inc.·4

Mar 19, 5:00 PM ET

Roberts Brandi 4

4 · Lineage Cell Therapeutics, Inc. · Filed Mar 19, 2020

Insider Transaction Report

Form 4
Period: 2020-03-17
Roberts Brandi
CFO & SVP, Finance
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-03-17+616,700616,700 total
    Exercise: $0.69Exp: 2030-03-17Common Shares (616,700 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest on March 17, 2021 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

Documents

1 file
  • 4
    ownership.xmlPrimary